Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1952 2
1955 1
1991 1
1993 9
1994 19
1995 25
1996 36
1997 38
1998 32
1999 59
2000 85
2001 73
2002 78
2003 77
2004 67
2005 82
2006 66
2007 49
2008 55
2009 54
2010 49
2011 60
2012 46
2013 64
2014 45
2015 52
2016 39
2017 43
2018 46
2019 39
2020 57
2021 42
2022 44
2023 27
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

1,469 results

Results by year

Filters applied: . Clear all
Page 1
Dalteparin sodium.
Pineo GF, Hull RD. Pineo GF, et al. Expert Opin Pharmacother. 2001 Aug;2(8):1325-37. doi: 10.1517/14656566.2.8.1325. Expert Opin Pharmacother. 2001. PMID: 11585001 Review.
Dalteparin sodium (Fragmin, Pharmacia Corporation) is a low molecular weight heparin (LMWH) with a mean molecular weight of approximately 5000 Da. ...Dalteparin sodium has been compared with heparin for the prevention of thrombotic complications during …
Dalteparin sodium (Fragmin, Pharmacia Corporation) is a low molecular weight heparin (LMWH) with a mean molecular weight of ap …
Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.
Dunn CJ, Sorkin EM. Dunn CJ, et al. Drugs. 1996 Aug;52(2):276-305. doi: 10.2165/00003495-199652020-00011. Drugs. 1996. PMID: 8841743 Review.
The majority of trails of patients receiving thromboprophylactic heparin perioperatively have shown similar efficacy of dalteparin sodium and UFH in the prevention of DVT and pulmonary embolism (PE), although 2 groups of investigators reported superior antithromboti …
The majority of trails of patients receiving thromboprophylactic heparin perioperatively have shown similar efficacy of dalteparin …
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.
McBane RD 2nd, Wysokinski WE, Le-Rademacher JG, Zemla T, Ashrani A, Tafur A, Perepu U, Anderson D, Gundabolu K, Kuzma C, Perez Botero J, Leon Ferre RA, Henkin S, Lenz CJ, Houghton DE, Vishnu P, Loprinzi CL. McBane RD 2nd, et al. J Thromb Haemost. 2020 Feb;18(2):411-421. doi: 10.1111/jth.14662. Epub 2019 Nov 28. J Thromb Haemost. 2020. PMID: 31630479 Free article. Clinical Trial.
Major bleeding occurred in 0% of 145 patients receiving apixaban, compared with 1.4% of 142 patients receiving dalteparin [P = .138; hazard ratio (HR) not estimable because of 0 bleeding event in apixaban group]. Recurrent VTE occurred in 0.7% of apixaban, compared to 6.3% …
Major bleeding occurred in 0% of 145 patients receiving apixaban, compared with 1.4% of 142 patients receiving dalteparin [P = .138; …
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators. Raskob GE, et al. N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Free article. Clinical Trial.
METHODS: In this open-label, noninferiority trial, we randomly assigned patients with cancer who had acute symptomatic or incidental venous thromboembolism to receive either low-molecular-weight heparin for at least 5 days followed by oral edoxaban at a dose of 60 mg once daily ( …
METHODS: In this open-label, noninferiority trial, we randomly assigned patients with cancer who had acute symptomatic or incidental venous …
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer.
Agnelli G, Muñoz A, Franco L, Mahé I, Brenner B, Connors JM, Gussoni G, Hamulyak EN, Lambert C, Suero MR, Bauersachs R, Torbicki A, Becattini C. Agnelli G, et al. Thromb Haemost. 2022 May;122(5):796-807. doi: 10.1055/s-0041-1735194. Epub 2021 Sep 16. Thromb Haemost. 2022. PMID: 34530482 Clinical Trial.
The rates of major bleeding in patients treated with apixaban or dalteparin was similar across patients with different cancer sites. ...Oral apixaban is a valid oral alternative to subcutaneous dalteparin for the treatment of a large spectrum of patients with cancer …
The rates of major bleeding in patients treated with apixaban or dalteparin was similar across patients with different cancer sites. …
New Pediatric Indication for Dalteparin Sodium.
Aschenbrenner DS. Aschenbrenner DS. Am J Nurs. 2019 Oct;119(10):22. doi: 10.1097/01.NAJ.0000586148.11015.7e. Am J Nurs. 2019. PMID: 31567246 No abstract available.
Dalteparin: a low-molecular-weight heparin.
Howard PA. Howard PA. Ann Pharmacother. 1997 Feb;31(2):192-203. doi: 10.1177/106002809703100212. Ann Pharmacother. 1997. PMID: 9034422 Review.
DATA SOURCES: A MEDLINE search identified pertinent English-language publications on dalteparin and venous thromboembolism. Key search terms were dalteparin, Fragmin, LMWH, and venous thromboembolism. ...Dalteparin is indicated for prophylaxis against DVT in …
DATA SOURCES: A MEDLINE search identified pertinent English-language publications on dalteparin and venous thromboembolism. Key searc …
Dalteparin-sodium induced drug fever in a neonate.
Wackernagel D, Obaya S, Nydert P. Wackernagel D, et al. BMJ Case Rep. 2016 Oct 13;2016:bcr2016217621. doi: 10.1136/bcr-2016-217621. BMJ Case Rep. 2016. PMID: 27737872 Free PMC article.
Drug fever caused by dalteparin-sodium (DS), a low-molecular-weight derivative of heparin, is neither listed in the official drug information and nor published as a case report until today. ...
Drug fever caused by dalteparin-sodium (DS), a low-molecular-weight derivative of heparin, is neither listed in the official d …
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes.
Kirkham K, Munson JM, McCluskey SV, Graner KK. Kirkham K, et al. Int J Pharm Compd. 2017 Sep-Oct;21(5):426-429. Int J Pharm Compd. 2017. PMID: 29216619
The stability of dalteparin 1,000 units/mL in 0.9% sodium chloride for injection stored in polypropylene syringes under refrigeration was examined. Dalteparin 1,000-units/mL syringes were prepared by adding 9 mL of 0.9% sodium chloride for injection to …
The stability of dalteparin 1,000 units/mL in 0.9% sodium chloride for injection stored in polypropylene syringes under refrig …
Role of dalteparin sodium on the growth of cancer cells and tumor-associated angiogenesis in A549 human lung cancer cell line and grafted mouse model.
Rui Y, Wang D, Hu D, Huang L. Rui Y, et al. J Cancer Res Ther. 2018 Dec;14(Supplement):S985-S992. doi: 10.4103/0973-1482.192765. J Cancer Res Ther. 2018. PMID: 30539834 Free article.
MATERIALS AND METHODS: A549 human lung adenocarcinoma cell line was divided into control group, treated using normal saline (NS); and dalteparin sodium groups, receiving 5, 15, 50, and 150 IU/ml of dalteparin sodium, respectively. ...In the human A549- …
MATERIALS AND METHODS: A549 human lung adenocarcinoma cell line was divided into control group, treated using normal saline (NS); and dal …
1,469 results